SpineVision® Expands Flex+2™ Product Family, Also Extends Marketing Presence In South America

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

ANTONY, France--(BUSINESS WIRE)--SpineVision®, a commercial-stage medical device company that designs, develops and markets products for the surgical treatment of spine disorders, announced today that it has: (1) expanded its Flex+2™ dynamic stabilization platform offerings with the addition of the prebent Flex+™2 for use in hybrid cases; and, (2) received regulatory approval to market its Flex+2™ products in Brazil.

Help employers find you! Check out all the jobs and post your resume.
MORE ON THIS TOPIC